Page 3 - Nasdaq Tern News Today

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) has been assigned an average rating of “Moderate Buy” from the nine research firms that are covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12 month price objective […]

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report)’s stock price was up 5.9% during mid-day trading on Friday . The stock traded as high as $9.01 and last traded at $8.97. Approximately 440,929 shares were traded during trading, a decline of 17% from the average daily volume of 528,878 shares. The stock had previously closed at […]

Research analysts at Mizuho started coverage on shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) in a research report issued on Thursday, The Fly reports. The firm set a “buy” rating and a $16.00 price target on the stock. Mizuho’s price target suggests a potential upside of 46.25% from the company’s current price. A number […]

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Rating) has earned a consensus recommendation of “Moderate Buy” from the eight analysts that are presently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month price objective among brokerages […]

Roth Mkm started coverage on shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) in a research report sent to investors on Wednesday morning, Briefing.com reports. The firm issued a buy rating and a $23.00 price objective on the stock. A number of other equities analysts also recently commented on TERN. HC Wainwright lifted their target […]

Roth Mkm started coverage on shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) in a research report released on Wednesday morning, Briefing.com reports. The brokerage issued a buy rating and a $23.00 price target on the stock. TERN has been the topic of a number of other reports. UBS Group initiated coverage on shares of […]

Equities research analysts at Roth Mkm initiated coverage on shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) in a research report issued to clients and investors on Wednesday, Briefing.com reports. The firm set a “buy” rating and a $23.00 price target on the stock. Roth Mkm’s price objective points to a potential upside of 103.54% […]

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Rating)’s stock price traded up 6% during mid-day trading on Monday . The company traded as high as $11.05 and last traded at $10.70. 39,619 shares traded hands during mid-day trading, a decline of 89% from the average session volume of 349,938 shares. The stock had previously closed at […]

Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) and TransCode Therapeutics (NASDAQ:RNAZ – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation. Insider and Institutional Ownership 15.9% of TransCode Therapeutics shares […]

BMO Capital Markets assumed coverage on shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) in a research note released on Monday, The Fly reports. The brokerage issued an outperform rating and a $18.00 price target on the stock. Several other equities analysts have also recently weighed in on TERN. UBS Group initiated coverage on shares […]